Kane Biotech Inc. (TSXV:KNE)

Canada · Delayed Price · Currency is CAD

0.0350

-0.0050 (-12.50%)

Mar 2, 2026, 1:11 PM EST

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Animal Health	2.49M	2.78M	-	-	-
Animal Health Growth	-10.56%	-	-	-	-
Human Health	675.37K	39.09K	-	-	-
Human Health Growth	1627.55%	-	-	-	-
ALL Other Segments	-	-	156.73K	-	-
Total	3.16M	2.82M	156.73K	-	-
Total Growth	12.17%	1697.82%	-	-	-

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Canada	1.01M	1.37M	35.23K	931.95K	668.27K
Canada Growth	-26.57%	3791.03%	-96.22%	39.46%	14.18%
International	2.15M	1.45M	121.50K	675.82K	673.30K
International Growth	48.87%	1090.85%	-82.02%	0.37%	-39.25%
Total	3.16M	2.82M	156.73K	1.61M	1.34M
Total Growth	12.17%	1697.82%	-90.25%	19.84%	-20.78%

Source: S&P Global Market Intelligence.